Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BRCA1-A complex subunit Abraxas 1 (ABRAXAS1) is a central scaffold protein within the BRCA1-A complex, functioning as an adaptor that links BRCA1 to other complex members such as RAP80, MERIT40, BRCC45, and BRCC36[2][3]. ABRAXAS1 is crucial for orchestrating the recruitment of BRCA1 to DNA double-strand breaks, thereby enabling effective DNA damage checkpoint activation and homologous recombination repair[1]. Germline and somatic mutations, as well as loss of function or reduced expression of ABRAXAS1, are associated with the development of several human cancers, mainly due to impaired DNA repair and loss of genome stability[1][2]. Despite its role in pathways intimately linked to cancer and DNA repair, ABRAXAS1 is not itself currently viewed as a direct therapeutic target or receptor, enzyme, or transporter. Rather, it is a tumor suppressor and DNA repair adaptor protein whose loss or mutation contributes indirectly to cancer pathogenesis[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BRCA1-A complex subunit Abraxas 1 (ABRAXAS1).